Xcout Intel
Affinivax, Inc.
Affinivax, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that pioneered a novel class of multiplex vaccine technologies.
Subscribe to see Affinivax, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Affinivax, Inc. at a glance
Affinivax, Inc. is a biotechnology company headquartered in United States. It has raised at least $353M across the 4 funding rounds on record, 3 of them with a disclosed amount. Its most recent funding round raised $226M in January 2021. Xcout tracks 1 named person at Affinivax, Inc., including Tony Wood (Chief Scientific Officer, GSK).
Affinivax, Inc. leadership
- Tony WoodChief Scientific Officer, GSK
Affinivax, Inc. funding rounds
At least $353M raised across the 4 rounds on record (3 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $226M | — | |
| Series B | $120M | 3 named | |
| SEC Form D filing | $7M | — | |
| Seed and Series A | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Affinivax, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Affinivax, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access